Trending News
News
News
Adocia Announces Failure of Phase 3 Trial
Adocia reports on the Phase 3 Trial of BioChaperone PDGF in the treatment of diabetic foot ulcer (DFU).
News
Breakthrough in GPCR Understanding
Integral Molecular announces breakthrough in understanding the functionality of GPCRs, the largest class of drug targets in human disease.
News
Propanc, AmatsiQBiologicals Announce Agreement
The agreement covers the development and production of PRP for human use in first-in-man studies.
News
Bio Pharma Acquires IP and HR Assets of BLS
Acquisition to expand and fortify its analytical services and become a global leader in clinical research.
News
Bayer, CRISPR Therapeutics Establish JV
Joint venture to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease.
News
Symmetry is Key to Collagen
Researchers describe how symmetry may be the key to growing collagen fibres outside the body.
News
Oxygen Can Impair Cancer Immunotherapy
Researchers have identified a mechanism within the lungs where anticancer immune resposnse is inhibited.
News
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
News
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
News
BioLineRx, I-Bridge Capital Establish Joint Venture
JV will develop innovative clinical and pre-clinical therapeutic candidates originating primarily in Israel to serve the Chinese and global healthcare markets.
Advertisement